Literature DB >> 10391295

Coronary revascularization with arterial conduits collateral to the lower limb.

T Shimizu1, T Hirayama, K Ikeda, S Ito, S Ishimaru.   

Abstract

A 62-year-old man with left main coronary artery disease had coronary artery bypass grafting. Angiography disclosed total occlusion of the left common iliac artery. The left internal thoracic artery and the left inferior epigastric artery were well developed as collateral pathways to the left external iliac artery. With concomitant femoro-femoral crossover bypass, these two large arterial conduits were harvested and grafted to the coronary artery.

Entities:  

Mesh:

Year:  1999        PMID: 10391295     DOI: 10.1016/s0003-4975(99)00334-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Abnormal origin of the left internal thoracic artery detected only by computed tomography.

Authors:  Kelly S McMaster; Jean-Michael B Blanc; Baron L Hamman; Robert L Rosenthal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

2.  Deep inferior epigastric artery as a collateral pathway to the lower extremities: A case report.

Authors:  Kaoru Tada; Atsuro Murai; Yuta Nakamura; Seigo Suganuma; Hiroyuki Tsuchiya
Journal:  JPRAS Open       Date:  2022-01-23

3.  Arterial myocardial revascularization with right internal thoracic artery and epigastric artery in a patient with Leriche's syndrome.

Authors:  Dmitry Bobylev; Felix Fleissner; Ruoyu Zhang; Axel Haverich; Issam Ismail
Journal:  J Cardiothorac Surg       Date:  2013-03-23       Impact factor: 1.637

4.  The use of both internal thoracic arteries for coronary revascularization increases the estimate of post-operative lower limb ischemia in patients with peripheral artery disease.

Authors:  Linda Renata Micali; Massimo Bonacchi; Daniel Weigel; Rosie Howe; Orlando Parise; Gianmarco Parise; Sandro Gelsomino
Journal:  J Cardiothorac Surg       Date:  2020-09-25       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.